Infographic: Public opinion about COVID-19 vaccination

View data around people’s potential acceptance of a COVID-19 vaccine, their concerns about safety, and trust in public health authorities.
Download infographic Get in touch
COVID19 Vaccination Public Opinion
Emmanuel Rivière

CEO, Public Division, France

Get in touch

Following the announcement on 9 November 2020 by Pfizer and its partner BioNTech that their vaccine appears to be 90% successful in preventing COVID-19, Kantar spoke with 7,000 people across Australia, France, Germany, Great Britain, Italy, Singapore and the USA to assess their views on vaccination against the coronavirus disease.

COVID-19 vaccine acceptance

Our research revealed an increasing hesitancy among the general population to commit to a COVID-19 vaccine, with only a minority saying that they will ‘definitely’ take such vaccine when it becomes available. These findings present a major challenge for governments around the world aiming to control the COVID-19 pandemic and get their economies back on track in 2021.

This infographic highlights some key differences between the seven countries surveyed, in terms of propensity to be vaccinated and trust in policy and in the pharmaceutical sector.

covid19 vaccine acceptance

COVID19 vaccine study

Download the full infographic here.

You can also read more about views on COVID-19 vaccines in the UK here.

For more information, including detailed findings by country, gender or age group, don’t hesitate to contact us.

Get in touch
Related solutions
Monitor and understand public opinion and social trends, with world-class research from Kantar.
Apply our systematic diagnosis to design, implement and evaluate behaviour-change policy, programmes and interventions.
Maximise the impact of your communication to the public, with our tools to guide strategy and evaluate campaigns.